SCHEMBL7901264

SCHEMBL7901264

c1ccc2c(c1)cnc1c3ccccc3c3c(c21)CCCC3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
GPR3 P46089 1/20 0.39
ACHE P22303 7/20 0.38
BCHE P06276 5/20 0.38
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
CACNB4 O00305 1/20 0.38
CACNA1A O00555 1/20 0.38
SLC22A2 O15244 1/20 0.38
SLC22A1 O15245 1/20 0.38
ABCC4 O15439 1/20 0.38
CACNA1G O43497 1/20 0.38
CACNG3 O60359 1/20 0.38
CACNA1F O60840 1/20 0.38
CACNA1H O95180 1/20 0.38
APP P05067 1/20 0.38
FABP1 P07148 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7900644 0.97 KDM4E (0.39) KDM4EGPR3ACHEBCHEALDH1A1
SCHEMBL7893958 0.93 KDM4E (0.41) KDM4EGPR3ACHEALDH1A1HSD17B10
SCHEMBL7901266 0.78 KIF11 (0.42) KDM4EGPR3ACHEBCHEALDH1A1
SCHEMBL16535869 0.76 KDM4E (0.48) KDM4EGPR3ALDH1A1TSHRHSD17B10
SCHEMBL11743927 0.75 KIF11 (0.43) KDM4EGPR3ACHEBCHEALDH1A1
SCHEMBL17409892 0.74 KIF11 (0.42) KDM4EGPR3ACHEBCHEALDH1A1
SCHEMBL7900647 0.74 KDM4E (0.41) KDM4EGPR3ACHEBCHEALDH1A1
SCHEMBL22049815 0.73 KDM4E (0.45) KDM4EGPR3ALDH1A1TSHRHSD17B10
SCHEMBL29374271 0.72 ACHE (0.46) KDM4EGPR3ACHEBCHEALDH1A1
SCHEMBL2921118 0.72 ACHE (0.46) KDM4EGPR3ACHEBCHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187783-B1 ANTITUMOR AGENTS NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2001-02-13 US disclosed